The blockage of NGF/Trk signaling with pan-Trk inhibitor PLX-7486 or the ablation of Tuft cells (a local source of ACh which stimulates cancer cells to produce NGF) within GC abrogates tumor development and decreases proliferation and tumorigenesis62. This evidence concerns the gene NTRK1 and gastric cancer.